SGLT2iDapagliflozin用于乳腺癌患者的化学疗法诱导心脏毒性的初级预防,这些患者接受了新辅助的基于人环素的化学疗法+/- trastuzumab:多中心PROTECT试验的推理和设计
A Greco1, V Quagliariello2, G Rizzo3
1Cardiology Division, Fondazione Policlinico San Matteo, IRCCS, Pavia, Italy.
Cardio-oncology (London, England)
|September 2, 2025
概括
这项随机试验研究了Dapagliflozin在接受 antracyclines 治疗的乳腺癌患者中的心脏保护作用. 这项研究旨在减少化疗引起的心脏毒性并改善心脏标志物.
科学领域:
- 心脏瘤学
- 药理学
- 癌症学
背景情况:
- 人环素会引起心脏毒性,这是乳腺癌患者的主要问题.
- 在临床前模型中,SGLT2抑制剂具有预防心脏毒性的潜力.
- 早期的研究表明,SGLT2i可能会降低在癌症患者中服用人环素的心脏事件.
研究的目的:
- 评估Dapagliflozin在接受基于人环素的化疗的早期乳腺癌患者的心脏保护作用.
- 评估心脏毒性发生率的降低和心脏代谢标记的改善.
主要方法:
- 随机试验比较Dapagliflozin加化疗与标准化疗.
- 参与治疗的患者有I-III阶段的乳腺癌,接受人环素+/- trastuzumab治疗.
- 在18个月内对心声图,心脏生物标志物和炎症标志物进行监测.
主要成果:
- 目前正在进行研究.
- 结果将在数据收集和分析完成后公布.
结论:
- 这项PROTECT试验是第一个对Dapagliflozin进行的随机研究,该研究涉及乳腺癌中与环素相关的心脏毒性.
- 这些发现可以为新的心脏瘤学策略提供信息,以提高患者的生活质量和心脏结果.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
288
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
288
Dipeptidyl Peptidase 4 Inhibitors
252
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
252
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


